Loading
Loss of an inherited HLA gene version can change which peptide-presenting molecules a tumour retains.
Human leukocyte antigen molecules normally present peptides to immune cells. HLA loss of heterozygosity concerns which inherited DNA versions remain in the sampled tumour, separately from their expression or current peptide display.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/